Frequent inactivation of A20 in B-cell lymphomas (original) (raw)
Accession codes
Primary accessions
Gene Expression Omnibus
Data deposits
The copy number data as well as the raw microarray data will be accessible from the GEO (http://ncbi.nlm.nih.gov/geo/) with the accession number GSE12906.
References
- Dixit, V. M. et al. Tumor necrosis factor-α induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin. J. Biol. Chem. 265, 2973–2978 (1990)
CAS PubMed Google Scholar - Song, H. Y., Rothe, M. & Goeddel, D. V. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-κB activation. Proc. Natl Acad. Sci. USA 93, 6721–6725 (1996)
Article ADS CAS PubMed PubMed Central Google Scholar - Lee, E. G. et al. Failure to regulate TNF-induced NF-κB and cell death responses in A20-deficient mice. Science 289, 2350–2354 (2000)
Article ADS CAS PubMed PubMed Central Google Scholar - Boone, D. L. et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nature Immunol. 5, 1052–1060 (2004)
Article CAS Google Scholar - Wang, Y. Y., Li, L., Han, K. J., Zhai, Z. & Shu, H. B. A20 is a potent inhibitor of TLR3- and Sendai virus-induced activation of NF-κB and ISRE and IFN-β promoter. FEBS Lett. 576, 86–90 (2004)
Article CAS PubMed Google Scholar - Wertz, I. E. et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling. Nature 430, 694–699 (2004)
Article ADS CAS PubMed Google Scholar - Heyninck, K. & Beyaert, R. A20 inhibits NF-κB activation by dual ubiquitin-editing functions. Trends Biochem. Sci. 30, 1–4 (2005)
Article CAS PubMed Google Scholar - Graham, R. R. et al. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nature Genet. 40, 1059–1061 (2008)
Article CAS PubMed Google Scholar - Musone, S. L. et al. Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. Nature Genet. 40, 1062–1064 (2008)
Article CAS PubMed Google Scholar - Jaffe, E. S., Harris, N. L., Stein, H. & Vardiman, J. W. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Hematopoietic and Lymphoid Tissues (IARC Press, 2001)
Google Scholar - Klein, U. & Dalla-Favera, R. Germinal centres: role in B-cell physiology and malignancy. Nature Rev. Immunol. 8, 22–33 (2008)
Article CAS Google Scholar - Nannya, Y. et al. A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. Cancer Res. 65, 6071–6079 (2005)
Article CAS PubMed Google Scholar - Yamamoto, G. et al. Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays. Am. J. Hum. Genet. 81, 114–126 (2007)
Article CAS PubMed PubMed Central Google Scholar - Jost, P. J. & Ruland, J. Aberrant NF-κB signaling in lymphoma: mechanisms, consequences, and therapeutic implications. Blood 109, 2700–2707 (2007)
CAS PubMed Google Scholar - Durkop, H., Hirsch, B., Hahn, C., Foss, H. D. & Stein, H. Differential expression and function of A20 and TRAF1 in Hodgkin lymphoma and anaplastic large cell lymphoma and their induction by CD30 stimulation. J. Pathol. 200, 229–239 (2003)
Article PubMed Google Scholar - Honma, K. et al. TNFAIP3 is the target gene of chromosome band 6q23.3-q24.1 loss in ocular adnexal marginal zone B cell lymphoma. Genes Chromosom. Cancer 47, 1–7 (2008)
Article CAS PubMed Google Scholar - Sarma, V. et al. Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis. J. Biol. Chem. 270, 12343–12346 (1995)
Article CAS PubMed Google Scholar - Fries, K. L., Miller, W. E. & Raab-Traub, N. The A20 protein interacts with the Epstein-Barr virus latent membrane protein 1 (LMP1) and alters the LMP1/TRAF1/TRADD complex. Virology 264, 159–166 (1999)
Article CAS PubMed Google Scholar - Hiramatsu, H. et al. Complete reconstitution of human lymphocytes from cord blood CD34+cells using the NOD/SCID/γnullmice model. Blood 102, 873–880 (2003)
Article CAS PubMed Google Scholar - Hsu, P. L. & Hsu, S. M. Production of tumor necrosis factor-α and lymphotoxin by cells of Hodgkin’s neoplastic cell lines HDLM-1 and KM-H2. Am. J. Pathol. 135, 735–745 (1989)
CAS PubMed PubMed Central Google Scholar - Dierlamm, J. et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 93, 3601–3609 (1999)
CAS PubMed Google Scholar - Willis, T. G. et al. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 96, 35–45 (1999)
Article CAS PubMed Google Scholar - Joos, S. et al. Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2. Blood 99, 1381–1387 (2002)
Article CAS PubMed Google Scholar - Martin-Subero, J. I. et al. Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma. Blood 99, 1474–1477 (2002)
Article CAS PubMed Google Scholar - Lenz, G. et al. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science 319, 1676–1679 (2008)
Article ADS CAS PubMed Google Scholar - Deacon, E. M. et al. Epstein-Barr virus and Hodgkin’s disease: transcriptional analysis of virus latency in the malignant cells. J. Exp. Med. 177, 339–349 (1993)
Article CAS PubMed Google Scholar - Yin, M. J. et al. HTLV-I Tax protein binds to MEKK1 to stimulate IκB kinase activity and NF-κB activation. Cell 93, 875–884 (1998)
Article CAS PubMed Google Scholar - Isaacson, P. G. & Du, M. Q. MALT lymphoma: from morphology to molecules. Nature Rev. Cancer 4, 644–653 (2004)
Article CAS Google Scholar - Skinnider, B. F. & Mak, T. W. The role of cytokines in classical Hodgkin lymphoma. Blood 99, 4283–4297 (2002)
Article CAS PubMed Google Scholar
Acknowledgements
This work was supported by the Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, by the 21st century centre of excellence program ‘Study on diseases caused by environment/genome interactions’, and by Grant-in-Aids from the Ministry of Education, Culture, Sports, Science and Technology of Japan and from the Ministry of Health, Labor and Welfare of Japan for the 3rd-term Comprehensive 10-year Strategy for Cancer Control. We also thank Y. Ogino, E. Matsui and M. Matsumura for their technical assistance.
Author Contributions M.Ka., K.N. and M.S. performed microarray experiments and subsequent data analyses. M.Ka., Y.C., K.Ta., J.T., J.N., M.I., A.T. and Y.K. performed mutation analysis of A20. M.Ka., S.Mu., M.S., Y.C. and Y.Ak. conducted functional assays of mutant A20. Y.S., K.Ta., Y.As., H.M., M.Ku., S.Mo., S.C., Y.K., K.To. and Y.I. prepared tumour specimens. I.K., K.O., A.N., H.N. and T.N. conducted in vivo tumorigenicity experiments in NOG/SCID mice. T.I., Y.H., T.Y., Y.K. and S.O. designed overall studies, and S.O. wrote the manuscript. All authors discussed the results and commented on the manuscript.
Author information
Authors and Affiliations
- Department of,, Cancer Genomics Project,
Motohiro Kato, Masashi Sanada, Junko Takita, Yuyan Chen, Kumi Nakazaki, Satsuki Muto, Azusa Tamura, Mitsuru Iio & Seishi Ogawa - Pediatrics,,
Motohiro Kato, Junko Takita, Yuyan Chen & Takashi Igarashi - Cell Therapy and Transplantation Medicine, and,,
Junko Takita & Shigeru Chiba - Hematology and Oncology, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan ,
Kumi Nakazaki & Mineo Kurokawa - Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, 4-1-8, Honcho, Kawaguchi-shi, Saitama 332-0012, Japan ,
Masashi Sanada, Kumi Nakazaki & Seishi Ogawa - Department of Pediatrics, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan,
Itaru Kato, Akira Niwa & Tatsutoshi Nakahata - Department of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan,
Yasuharu Sato & Tadashi Yoshino - Division of Pathology, The Cancer Institute of Japanese Foundation for Cancer Research, Japan, 3-10-6 Ariake, Koto-ku, Tokyo 135-8550, Japan,
Kengo Takeuchi & Yuichi Ishikawa - Hematology Division, Hospital, and,
Junko Nomoto, Yoshitaka Asakura, Kensei Tobinai & Yukio Kobayashi - Early Oncogenesis Research Project, Research Institute, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan ,
Koji Okamoto & Hitoshi Nakagama - Division of Immunology, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya 464-8681, Japan,
Yoshiki Akatsuka - Gunma Children’s Medical Center, 779 Shimohakoda, Hokkitsu-machi, Shibukawa 377-8577, Japan ,
Yasuhide Hayashi - Division of Hematology, Internal Medicine, Showa University Fujigaoka Hospital, 1-30, Fujigaoka, Aoba-ku, Yokohama-shi, Kanagawa 227-8501, Japan,
Hiraku Mori - Department of Pathology, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo 173-8605, Japan,
Shigeo Mori
Authors
- Motohiro Kato
You can also search for this author inPubMed Google Scholar - Masashi Sanada
You can also search for this author inPubMed Google Scholar - Itaru Kato
You can also search for this author inPubMed Google Scholar - Yasuharu Sato
You can also search for this author inPubMed Google Scholar - Junko Takita
You can also search for this author inPubMed Google Scholar - Kengo Takeuchi
You can also search for this author inPubMed Google Scholar - Akira Niwa
You can also search for this author inPubMed Google Scholar - Yuyan Chen
You can also search for this author inPubMed Google Scholar - Kumi Nakazaki
You can also search for this author inPubMed Google Scholar - Junko Nomoto
You can also search for this author inPubMed Google Scholar - Yoshitaka Asakura
You can also search for this author inPubMed Google Scholar - Satsuki Muto
You can also search for this author inPubMed Google Scholar - Azusa Tamura
You can also search for this author inPubMed Google Scholar - Mitsuru Iio
You can also search for this author inPubMed Google Scholar - Yoshiki Akatsuka
You can also search for this author inPubMed Google Scholar - Yasuhide Hayashi
You can also search for this author inPubMed Google Scholar - Hiraku Mori
You can also search for this author inPubMed Google Scholar - Takashi Igarashi
You can also search for this author inPubMed Google Scholar - Mineo Kurokawa
You can also search for this author inPubMed Google Scholar - Shigeru Chiba
You can also search for this author inPubMed Google Scholar - Shigeo Mori
You can also search for this author inPubMed Google Scholar - Yuichi Ishikawa
You can also search for this author inPubMed Google Scholar - Koji Okamoto
You can also search for this author inPubMed Google Scholar - Kensei Tobinai
You can also search for this author inPubMed Google Scholar - Hitoshi Nakagama
You can also search for this author inPubMed Google Scholar - Tatsutoshi Nakahata
You can also search for this author inPubMed Google Scholar - Tadashi Yoshino
You can also search for this author inPubMed Google Scholar - Yukio Kobayashi
You can also search for this author inPubMed Google Scholar - Seishi Ogawa
You can also search for this author inPubMed Google Scholar
Corresponding authors
Correspondence toYukio Kobayashi or Seishi Ogawa.
Supplementary information
Supplementary Information
This file contains Supplementary Tables 1-6, Supplementary Figures 1-10 with Legends, and a Supplementary Reference. (PDF 2924 kb)
PowerPoint slides
Rights and permissions
About this article
Cite this article
Kato, M., Sanada, M., Kato, I. et al. Frequent inactivation of A20 in B-cell lymphomas.Nature 459, 712–716 (2009). https://doi.org/10.1038/nature07969
- Received: 17 September 2008
- Accepted: 03 March 2009
- Published: 03 May 2009
- Issue Date: 04 June 2009
- DOI: https://doi.org/10.1038/nature07969